Why Surgery Partners (SGRY) Stock Is Trading Up Today

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

SGRY Cover Image

What Happened?

Shares of healthcare company Surgery Partners (NASDAQ: SGRY) jumped 2.7% in the morning session after Cantor Fitzgerald reiterated its "Overweight" rating and an $18.00 price target on the stock. 

The firm's analyst acknowledged some slight negative trends in the company's second-quarter ambulatory surgery center and outpatient nursing data. However, the overall outlook remained positive. Despite potential operational headwinds, other analysts also predict Surgery Partners will be profitable this year, with net income expected to grow.

The shares were trading at $17.15, up 3.3% from the previous close.

Is now the time to buy Surgery Partners? Access our full analysis report here, it’s free.

What Is The Market Telling Us

Surgery Partners’s shares are somewhat volatile and have had 11 moves greater than 5% over the last year. In that context, today’s move indicates the market considers this news meaningful but not something that would fundamentally change its perception of the business.

The biggest move we wrote about over the last year was 8 months ago when the stock dropped 23.8% on the news that it reported third-quarter results that missed analyst expectations for profit and lowered its full-year 2025 financial forecast. 

The company's adjusted earnings per share of $0.13 fell short of consensus estimates. While revenue of $821.5 million was roughly in line with expectations, investors focused on the dimmer outlook for the remainder of the year. Surgery Partners reduced its full-year revenue projection to a range of $3.275 billion to $3.30 billion and its adjusted EBITDA guidance to between $535 million and $540 million.

Surgery Partners is up 12.4% since the beginning of the year, but at $17.15 per share, it is still trading 28.1% below its 52-week high of $23.84 from August 2025. Despite the year-to-date gain, investors who bought $1,000 worth of Surgery Partners’s shares 5 years ago would now be looking at only $262.50.

ONE MORE THING: 3 Hidden Platforms Growing 3X Faster than Amazon, Google, and PayPal. Amazon, Google, and Meta all followed the same playbook: Dominate an ignored market. Build an unbeatable moat. Scale until you’re unstoppable.

These three platforms are running that exact playbook right now. The early investors in Amazon made fortunes. The early investors in these could do the same. Get All 3 Stocks Here for FREE.

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  243.86
+2.16 (0.89%)
AAPL  308.01
+13.63 (4.63%)
AMD  510.32
-30.56 (-5.65%)
BAC  58.35
-0.01 (-0.01%)
GOOG  353.22
-4.67 (-1.30%)
META  584.23
-28.68 (-4.68%)
MSFT  390.40
+6.12 (1.59%)
NVDA  192.82
-4.76 (-2.41%)
ORCL  139.24
-3.26 (-2.29%)
TSLA  390.17
-35.13 (-8.26%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.